OBJECTIVE: The dose-response effects of dysferlin transgenesis were analyzed to determine if the dysferlin-deficient myopathies are good candidates for gene replacement therapy. METHODS: We have generated 3 lines of transgenic mice, expressing low, mid, and high levels of full-length human dysferlin from a muscle-specific promoter. Transgenic skeletal muscle was analyzed and scored for morphological and functional deficits. RESULTS: Overexpression of dysferlin in mice resulted in a striking phenotype of kyphosis, irregular gait, and reduced muscle mass and strength. Moreover, protein dosage correlated with phenotype severity. In contrast to dysferlin-null skeletal muscle, no evidence of sarcolemmal impairment was revealed. Rather, increased levels of Ca(2+)-regulated, dysferlin-binding proteins and endoplasmic reticulum stress chaperone proteins were observed in muscle lysates from transgenic mice as compared with controls. INTERPRETATION: Expression levels of dysferlin are important for appropriate function without deleterious or cytotoxic effects. As a corollary, we propose that future endeavors in gene replacement for correction of dysferlinopathy should be tailored to take account of this.
OBJECTIVE: The dose-response effects of dysferlin transgenesis were analyzed to determine if the dysferlin-deficient myopathies are good candidates for gene replacement therapy. METHODS: We have generated 3 lines of transgenic mice, expressing low, mid, and high levels of full-length humandysferlin from a muscle-specific promoter. Transgenic skeletal muscle was analyzed and scored for morphological and functional deficits. RESULTS: Overexpression of dysferlin in mice resulted in a striking phenotype of kyphosis, irregular gait, and reduced muscle mass and strength. Moreover, protein dosage correlated with phenotype severity. In contrast to dysferlin-null skeletal muscle, no evidence of sarcolemmal impairment was revealed. Rather, increased levels of Ca(2+)-regulated, dysferlin-binding proteins and endoplasmic reticulum stress chaperone proteins were observed in muscle lysates from transgenic mice as compared with controls. INTERPRETATION: Expression levels of dysferlin are important for appropriate function without deleterious or cytotoxic effects. As a corollary, we propose that future endeavors in gene replacement for correction of dysferlinopathy should be tailored to take account of this.
Authors: Mengfatt Ho; Eduard Gallardo; Diane McKenna-Yasek; Noemi De Luna; Isabel Illa; Robert H Brown Journal: Ann Neurol Date: 2002-01 Impact factor: 10.422
Authors: Douglas P Millay; Marjorie Maillet; Joseph A Roche; Michelle A Sargent; Elizabeth M McNally; Robert J Bloch; Jeffery D Molkentin Journal: Am J Pathol Date: 2009-10-15 Impact factor: 4.307
Authors: M J Spencer; J R Guyon; H Sorimachi; A Potts; I Richard; M Herasse; J Chamberlain; I Dalkilic; L M Kunkel; J S Beckmann Journal: Proc Natl Acad Sci U S A Date: 2002-06-19 Impact factor: 11.205
Authors: Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez Journal: J Lipid Res Date: 2017-11-25 Impact factor: 5.922
Authors: David W Hammers; Margaret M Sleeper; Sean C Forbes; Cora C Coker; Michael R Jirousek; Michael Zimmer; Glenn A Walter; H Lee Sweeney Journal: JCI Insight Date: 2016-12-22
Authors: Gianina Ravenscroft; Irina T Zaharieva; Carlo A Bortolotti; Matteo Lambrughi; Marcello Pignataro; Marco Borsari; Caroline A Sewry; Rahul Phadke; Goknur Haliloglu; Royston Ong; Hayley Goullée; Tamieka Whyte; Uk K Consortium; Adnan Manzur; Beril Talim; Ulkuhan Kaya; Daniel P S Osborn; Alistair R R Forrest; Nigel G Laing; Francesco Muntoni Journal: Hum Mol Genet Date: 2018-12-15 Impact factor: 6.150